Fluoroquinolones in pediatrics and their nephrotoxicity in adults: minireview.
In recent years there is increasing pressure to use fluoroquinolones in pediatric patients but relatively few data have been published in the literature. Therefore this paper reviews the available information about the pharmacokinetics of fluoroquinolones in children and their use in pediatric urinary tract infections, taking into account their potential as nephrotoxic agents. From the available data it seems reasonable to suggest that there is no risk of quinolone-induced nephrotoxicity and that this class of antibiotics may therefore be considered as potential candidates in urinary tract infections in children. Nevertheless adequate pharmacokinetic investigations and further studies on long-term monitoring for potential toxicity need to be conducted in pediatric populations.
Fanos
V
V
Pediatric Department, University of Verona, Italy. vafanos@tin.it
Cuzzolin
L
L
D000328:Adult; D000890:Anti-Infective Agents / Q000009:adverse effects* / Q000493:pharmacokinetics* / Q000627:therapeutic use; D002648:Child; D024841:Fluoroquinolones; D006801:Humans; D007674:Kidney Diseases / Q000139:chemically induced*; D014552:Urinary Tract Infections / Q000188:drug therapy
D000890:Anti-Infective Agents; D024841:Fluoroquinolones